RESEARCH HUB · WOMEN 35+ GUMMY
A chain of 20 research artefacts on the women's functional gummy market for the clone-and-capture play. Three independent scoring lenses + real OASIS MiroFish simulation (108 agents × 565 actions) + 6-Q deep-mine surfacing 14 alpha quotes + new Felicia Adeyemi persona · composite 9.2/10. Bridge from strategy to factory wire + LLM swarm validation + chisel-level persona retrieval.
niche-launch-research skill. Audits 4 SKUs (REVIVE/CALM/PIVOT/BLOOM) against women-45-60-specific pain hierarchy. Top pains: hot flash · libido · joint pain (uncovered) · vaginal dryness · stress. PIVOT scores 9/10 fit · BLOOM 8 · CALM 6 · REVIVE 5. Structural gap = bone+joint. Verdict: bundle-test Option B first, FORTIFY only if bundle wins. Doctrine 8 added.market-survey-deep-research v1.0.0. Nutrafol $3.5B Unilever exit · Bonafide $425M Pharmavite · Goli bankruptcy 2024 · Uqora Pharmavite 2021 · Vegamour $80M raised. Surfaces the Pharmavite (Otsuka Pharma Japan) women's-health rollup as the structural threat — they own Bonafide + Uqora + Nature Made all-at-once. Doctrine 11 proposed: cross-bundle by Day 14 to compound LTV against rollup. 10-year category exit timeline.